Sanofi’s strength in molecular oncology is likely to provide it a competitive edge over its peers as to what drives the growth of cancer tissues, how these cells functions and proliferation in the body. In a strategic development, French drugmaker,… Read More ›
Jean-Paul Agon, L‘Oreal CEO made these comments while releasing the firm’s 4th quarter results. On Friday, L‘Oreal Chief Executive stated, the French cosmetic giant is ready to purchase Nestle’s 23% stake in the firm if Nestle decides to sell it…. Read More ›
Sanofi has clarified, it has not received any evidence of heightened incidence of severe dengue in vaccinated individuals in real world incidents. Sanofi’s dengue vaccine has got itself into a spot of trouble with the World Health Organization calling for… Read More ›
Without this divesture, there is likely to be reduced competition among vaccine manufacturers in the U.S. and EU. The divesture is key to their $13.5 billion deal. So as to streamline Boehringer Ingelheim acquisition of Sanofi, the German pharmaceutical maker… Read More ›
manageria.biz 